Dena Moskowitz1, Jenny Chang2, Argyrios Ziogas2, Hoda Anton-Culver2, Ralph V Clayman3. 1. Department of Urology, University of California, Irvine, Irvine, California. Electronic address: dvanlier@uci.edu. 2. Department of Epidemiology, University of California, Irvine, Irvine, California. 3. Department of Urology, University of California, Irvine, Irvine, California.
Abstract
PURPOSE: Due to the widespread use of computerized tomography, the diagnosis of small renal cancers (3 cm or less) within the T1a classification continues to increase. Current treatment of these tumors includes radical nephrectomy, partial nephrectomy and thermal ablation. We used the SEER (Surveillance, Epidemiology, and End Results) Program to compare treatment modalities for these cancers based on 1 cm increments in tumor size. We examined overall survival, cancer specific survival, survival from cardiovascular disease and race based treatment disparities. MATERIALS AND METHODS: In the SEER database we identified 17,716 renal cancers 3 cm or less diagnosed from 2005 to 2010 treated with radical nephrectomy, partial nephrectomy or thermal ablation. Overall survival, cancer specific survival and cardiovascular survival were determined for each treatment group, and then substratified by size in centimeters, tumor grade, age, geographical location and ethnicity. Survival was analyzed using Kaplan-Meier methods, multivariate proportional hazards models and a propensity score weighted approach. RESULTS: Overall survival, cancer specific survival and cardiovascular survival were better for partial nephrectomy than radical nephrectomy in all circumstances. Thermal ablation showed equivalent overall survival to partial nephrectomy for tumors 2 cm or less. Notably, radical nephrectomy for renal tumors 3 cm or less was applied in a disparately larger number of black patients (OR 1.63, 95% CI 1.47-1.81) and Hispanic patients (OR 1.28, 95% CI 1.14-1.44). CONCLUSIONS: Radical nephrectomy should be avoided for all tumors 3 cm or less. For renal cancers 2 cm or less partial nephrectomy and thermal ablation are equally effective. For tumors 2.1 to 3 cm partial nephrectomy is better than thermal ablation. We identified significant racial treatment disparities that negatively impact survival in black and Hispanic patients.
PURPOSE: Due to the widespread use of computerized tomography, the diagnosis of small renal cancers (3 cm or less) within the T1a classification continues to increase. Current treatment of these tumors includes radical nephrectomy, partial nephrectomy and thermal ablation. We used the SEER (Surveillance, Epidemiology, and End Results) Program to compare treatment modalities for these cancers based on 1 cm increments in tumor size. We examined overall survival, cancer specific survival, survival from cardiovascular disease and race based treatment disparities. MATERIALS AND METHODS: In the SEER database we identified 17,716 renal cancers 3 cm or less diagnosed from 2005 to 2010 treated with radical nephrectomy, partial nephrectomy or thermal ablation. Overall survival, cancer specific survival and cardiovascular survival were determined for each treatment group, and then substratified by size in centimeters, tumor grade, age, geographical location and ethnicity. Survival was analyzed using Kaplan-Meier methods, multivariate proportional hazards models and a propensity score weighted approach. RESULTS: Overall survival, cancer specific survival and cardiovascular survival were better for partial nephrectomy than radical nephrectomy in all circumstances. Thermal ablation showed equivalent overall survival to partial nephrectomy for tumors 2 cm or less. Notably, radical nephrectomy for renal tumors 3 cm or less was applied in a disparately larger number of black patients (OR 1.63, 95% CI 1.47-1.81) and Hispanic patients (OR 1.28, 95% CI 1.14-1.44). CONCLUSIONS: Radical nephrectomy should be avoided for all tumors 3 cm or less. For renal cancers 2 cm or less partial nephrectomy and thermal ablation are equally effective. For tumors 2.1 to 3 cm partial nephrectomy is better than thermal ablation. We identified significant racial treatment disparities that negatively impact survival in black and Hispanic patients.
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester Journal: Eur Urol Date: 2010-12-22 Impact factor: 20.096
Authors: Simon P Kim; R Houston Thompson; Stephen A Boorjian; Christopher J Weight; Leona C Han; M Hassan Murad; Nathan D Shippee; Patricia J Erwin; Brian A Costello; George K Chow; Bradley C Leibovich Journal: J Urol Date: 2012-05-14 Impact factor: 7.450
Authors: Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort Journal: Lancet Date: 2010-05-17 Impact factor: 79.321
Authors: Brian R Lane; Robert Abouassaly; Tianming Gao; Christopher J Weight; Adrian V Hernandez; Benjamin T Larson; Jihad H Kaouk; Inderbir S Gill; Steven C Campbell Journal: Cancer Date: 2010-07-01 Impact factor: 6.860
Authors: Phillip M Pierorazio; Michael H Johnson; Mark W Ball; Michael A Gorin; Bruce J Trock; Peter Chang; Andrew A Wagner; James M McKiernan; Mohamad E Allaf Journal: Eur Urol Date: 2015-02-16 Impact factor: 20.096
Authors: Simone L Vernez; Zhamshid Okhunov; Kamaljot Kaler; Ramy F Youssef; Rahul Dutta; Arkadiy Palvanov; Paras Shah; Kathryn Osann; David N Siegel; Igor Lobko; Louis Kavoussi; Ralph V Clayman; Jaime Landman Journal: Urology Date: 2017-06-23 Impact factor: 2.649
Authors: Alejandro Cruz; Faith Dickerson; Kathryn R Pulling; Kyle Garcia; Francine C Gachupin; Chiu-Hsieh Hsu; Juan Chipollini; Benjamin R Lee; Ken Batai Journal: Int J Environ Res Public Health Date: 2022-02-12 Impact factor: 3.390
Authors: Lucas Schulze; Victor Teixeira Dubeux; José C A Milfont; Gustavo Peçanha; Pedro Ferrer; Andre Guilherme Cavalcanti Journal: Int Braz J Urol Date: 2022 May-Jun Impact factor: 1.541